FDA Approves Orzeyful for Narcolepsy Type 1
Orzeyful is the first drug to target the underlying loss of orexin signaling to address the full range of narcolepsy type 1.
Breaking News
🔥 TOP 5 STORIES
Hantavirus Outbreak Highlights Person-to-Person Transmission Risks
A recent cruise ship outbreak of the Andes strain underscores the potential for silent spread and severe respiratory complications in travel networks.
The Latest News Delivered Directly to Your Inbox!
Join our mailing list to receive the latest news, information, and updates on the Respiratory Health.RT: The Digital Edition
Medtech & Pharma Breakthroughs
Duchenne Muscular Dystrophy Cell Therapy Preserves Heart, Muscle Function
Results from the HOPE-3 trial found that an investigational cell therapy called deramiocel preserved heart and muscle function in boys and young men with Duchenne muscular dystrophy (DMD).
Combatting Infectious Diseases
COPD & Asthma Updates
5 Tips for Back-to-School Allergy Management
The American College of Allergy, Asthma, and Immunology (ACAAI) outlines essential steps for families and school staff to navigate seasonal allergy triggers and respiratory health.
